Triple-negative breast cancer: current perspective on the evolving therapeutic landscape
Joe Mehanna,1 Fady GH Haddad,1 Roland Eid,1 Matteo Lambertini,2,3 Hampig Raphael Kourie11Oncology Department, Faculty of Medicine, Saint Joseph University of Beirut, Beirut, Lebanon; 2Department of Medical Oncology, U.O.C. Clinica Di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genova,...
Main Authors: | Mehanna J, Haddad FGH, Eid R, Lambertini M, Kourie HR |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2019-07-01
|
Series: | International Journal of Women's Health |
Subjects: | |
Online Access: | https://www.dovepress.com/triple-negative-breast-cancer-current-perspective-on-the-evolving-ther-peer-reviewed-article-IJWH |
Similar Items
-
Early Triple Negative Breast Cancer: Conventional Treatment and Emerging Therapeutic Landscapes
by: Anna Diana, et al.
Published: (2020-03-01) -
Novel therapeutic strategies for patients with metastatic triple-negative breast cancer
by: Inna P. Ganshina, et al.
Published: (2021-02-01) -
A review of current progress in triple-negative breast cancer therapy
by: Shen Meiying, et al.
Published: (2020-11-01) -
Current treatment landscape for patients with locally recurrent inoperable or metastatic triple-negative breast cancer: a systematic literature review
by: Claire H. Li, et al.
Published: (2019-12-01) -
An open-label, pilot study of veliparib and lapatinib in patients with metastatic, triple-negative breast cancer
by: Erica M. Stringer-Reasor, et al.
Published: (2021-03-01)